Join the Class Action Against MacroGenics: Claim Your Share
![Join the Class Action Against MacroGenics: Claim Your Share](https://investorshangout.com/images/blog/ihnews-Join%20the%20Class%20Action%20Against%20MacroGenics%3A%20Claim%20Your%20Share.jpg)
Join the Class Action Against MacroGenics, Inc.
Levi & Korsinsky, LLP is notifying investors in MacroGenics, Inc. (NASDAQ: MGNX) about an important class action securities lawsuit. This action aims to recover losses for investors adversely affected by alleged securities fraud. The timeline for the class period stretches from March 7, 2024, to May 9, 2024.
Understanding the Class Action Lawsuit
The lawsuit is focused on losses incurred by those who invested in MacroGenics during this specific period. The key issue centers around misrepresentations related to safety data from the company's TAMARACK Phase 2 study regarding vobramitamab duocarmazine. After disclosures regarding the drug's dangers, MGNX's stock plummeted 77.4%, corresponding to a loss of $11.36 per share.
What Investors Need to Know
Filing for Lead Plaintiff Status
If you experienced a loss in MacroGenics stocks during this timeframe, you have until September 24, 2024, to apply for lead plaintiff status. It's essential to understand that serving as a lead plaintiff is not a requirement to share in any recovery from the lawsuit.
No Financial Risk
Participating in the class action poses no financial burden to investors. If you are recognized as a class member, you may be entitled to compensation without needing to pay any fees or other costs upfront. This presents a significant opportunity for investors looking to reclaim losses.
Why Choose Levi & Korsinsky?
With a legacy of over 20 years, Levi & Korsinsky has recovered hundreds of millions of dollars for disgruntled shareholders across the United States. Their team is well-equipped to manage complex securities litigation, boasting over 70 dedicated professionals focused on supporting clients through challenging times. For seven consecutive years, they have been recognized as one of the top firms in securities litigation by ISS Securities Class Action Services.
Investor Outreach Details
If you are an investor seeking more information, you can contact Joseph E. Levi, Esq. at (212) 363-7500. Alternatively, feel free to reach out for further guidance regarding your options and potential benefits in participating in this class action.
Frequently Asked Questions
What is the deadline to join the class action against MacroGenics?
The deadline for investors to join the class action is September 24, 2024.
Who can join the class action lawsuit?
Any investor who suffered losses during the class period between March 7, 2024, and May 9, 2024, can join the lawsuit.
Are there any fees to participate?
No, class members may be entitled to compensation without any out-of-pocket costs or fees.
What does it mean to be a lead plaintiff?
Being a lead plaintiff means you would represent the class in the lawsuit, but it is not necessary to serve in this role to benefit from potential recoveries.
Why is Levi & Korsinsky a good choice for representation?
Levi & Korsinsky has a proven track record of recovering significant amounts for investors and is recognized among the top firms in securities litigation.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Related Articles
- Mobileye Shares Decline Amid Intel Ownership Changes
- Texas Capital Bancshares Strategizes for Future Growth
- Exciting New Stock Option Granted by Taysha Gene Therapies
- PTX Metals Implements Share Consolidation for Growth Strategy
- Innovative Collaboration in Psychedelic Therapy Patent Growth
- Michael Collins Joins Jacobs' Board to Enhance Leadership
- Exploring the Rising Hydrogen Aircraft Market's Future
- Nasdaq Strengthens Leadership to Enhance Financial Crime Solutions
- Understanding the Recent Changes in Alliance Trust PLC's NAV
- Navigating the AI Market: Supermicro and Dell's Strategies
Recent Articles
- Vicor Corporation Class Action: Important Information Inside
- Sprinklr, Inc. Investors Urged to Join Class Action Lawsuit
- Join Spire Global, Inc. Class Action and Protect Your Rights
- Investor Alert: Starbucks Class Action Lawsuit Update
- Orthofix Medical Faces Class Action: Know Your Rights
- Italy's President Emphasizes Urgent Need for Debt Reduction
- China's Major Brokerage Merger Sparks Industry Transformation
- Star Entertainment's $45 Million Casino Building Sale
- Top Three Dow Stocks to Consider for Future Growth
- Bitcoin Surpasses Stock Market in Trading Hours Since Launch
- Facing Pressure, Intel's CEO Explores AI Strategy Revamp
- ABM Industries Prepares for Earnings Report; Analysts Weigh In
- Salesforce's Bold Leap Into AI Agents with Agentforce
- Argan Inc. Sees Significant Share Price Increase Ahead
- Discover the Amazfit T-Rex 3: The Ultimate Adventure Smartwatch
- Market Outlook: Key Indicators for S&P 500 and Nasdaq Today
- Investment Surge: Tower Semiconductor Partners with Adani Group
- Exploring Zscaler's Potential in Today's Cybersecurity Landscape
- Global Aircraft Sequencing System Market to Reach $9.8B by 2033
- Man Group PLC Reveals Position Disclosure for Keywords Studios
- Man Group's Position Disclosure on Ascential Securities
- Exploring Daily Fund Prices of WisdomTree ETFs
- Leadership Transition at Storebæltsforbindelsen Signals Change
- Man Group PLC Reports Significant Position Details in DS Smith
- Leadership Transition at A/S Øresundsforbindelsen Announced
- Man Group PLC Details on International Paper Company Stake
- Investors Shift to Cash as Fed Rate Cut Anticipation Grows
- Future of Electrified Vehicles in Pakistan: BYD's Vision
- Japan Airlines Remains Confident Amid A350 Inspections
- BofA's Positive Outlook on Bayer's Stock Performance
- UK Competition Watchdog Challenges Google's Advertising Strategies
- Toyota Reduces Electric Vehicle Production Goals Significantly
- Exploring the Exceptional Growth of Semiconductor ETFs
- Understanding Stora Enso's Latest Nomination Board Members
- Qudian Inc. Delivers Strong Financial Performance for Q2 2024
- Key Insights from the Upcoming Extraordinary General Meeting
- Important Gathering to Discuss Future Directions of AS Storebælt
- Qudian Inc. Welcomes New Auditor BDO After Thoughtful Review
- Qudian's Latest Financial Report: Growth in Revenue for Q2 2024
- Expats Delight in Culture and Culinary Wonders of Lanxi
- Reolink Launches Altas PT Ultra: A Leap in Home Security Tech
- Pizza Hut Innovates with Budget-Friendly Options in China
- Strategic Investing: Leveraging Market Dips for Profits
- Taiwan Semiconductor: A Rising Giant in AI Innovation
- CrowdStrike's Journey: From Outage to Opportunity Ahead
- Toyota Reduces EV Production Goals Amid Market Slowdown
- ProVen VCT plc Announces Significant Voting Rights Update
- Voting Rights Update for ProVen Growth and Income VCT
- Understanding Stora Enso's Shareholders' Nomination Board
- Innovative AI Image Upscaler Transforms Your Picture Quality